KRYS · Krystal Biotech Inc
United States · RS rating 60 · As of 2026-11-03
| Price | 305.03 USD |
|---|---|
| 1-day change | +3.1% |
| RS rating (overall / 1M / 3M / 12M) | 60 / 37 / 53 / 86 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 36 / 46 / 27 |
| Industry group (rank) | Medical-Biomed/Biotech (154) |
| EPS growth Q/Q | -36.1% |
| Sales growth Q/Q | +9.5% |
| Distance from 52-week high | +19.3% |
| Market cap (USD) | $7.9B |